NASDAQ: ALNY - Alnylam Pharmaceuticals, Inc.
Yield per half year: +96.88%
Sector: Healthcare
Reporting Alnylam Pharmaceuticals, Inc.
Reports
IFRS
Annual
Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|
Финансовый отчет | link | link | link | link | link | link | link | link |
Capitalization
IFRS
Annual
Quarterly
Balance sheet
IFRS
Annual
Quarterly
Share
IFRS
Annual
Quarterly
Efficiency
IFRS
Annual
Quarterly
Coefficients
IFRS
Annual
Quarterly
Dividends
IFRS
Annual
Quarterly
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | LTM | Industry average | 5 year average | CAGR 5 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Дивиденд
|
0 | ||||||||||||
Див доход, ао, %
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.86 | ||
Дивиденды / прибыль, %
|
0 | 0 | 0 | 0 | 41.83 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription